![]()
GONUTS is under stress! The website is currently experiencing long-wait times and frequent time-outs due to the record number of students, groups, and annotations related to CACAO this semester. We are currently working on increasing performance -- please accept our apologies for the technical difficulties.
You can help reduce stress on the server by:
- not reloading pages frequently - this just adds
- opening links in new windows (so you can read the old page)
MGI:Hexb
Contents |
| Species (Taxon ID) | Mus musculus (house mouse) (taxon:10090) | |
| Gene Name(s) | Hexb | |
| Protein Name(s) | hexosaminidase B, | |
| External Links | ||
| MGI | MGI:96074 | |
Annotations
| Qualifier | GO ID | GO term name | Reference | Evidence Code | with/from | Aspect | Notes | Status |
|---|---|---|---|---|---|---|---|---|
| GO:0001501 |
skeletal system development |
MGI:MGI:83770 |
IGI: Inferred from Genetic Interaction |
MGI:MGI:96073 |
P |
From MGI |
||
| GO:0001501 |
skeletal system development |
MGI:MGI:894634 |
IGI: Inferred from Genetic Interaction |
MGI:MGI:96073 |
P |
From MGI |
||
| GO:0001669 |
acrosomal vesicle |
MGI:MGI:3582046 |
IDA: Inferred from Direct Assay |
C |
From MGI |
|||
| GO:0003824 |
catalytic activity |
MGI:MGI:2152098 |
IEA: Inferred from Electronic Annotation |
F |
From MGI |
|||
| GO:0004553 |
hydrolase activity, hydrolyzing O-glycosyl compounds |
MGI:MGI:2152098 |
IEA: Inferred from Electronic Annotation |
F |
From MGI |
|||
| GO:0004563 |
beta-N-acetylhexosaminidase activity |
MGI:MGI:1101658 |
IDA: Inferred from Direct Assay |
F |
From MGI |
|||
| GO:0004563 |
beta-N-acetylhexosaminidase activity |
MGI:MGI:3033879 |
IDA: Inferred from Direct Assay |
F |
From MGI |
|||
| GO:0004563 |
beta-N-acetylhexosaminidase activity |
MGI:MGI:3582046 |
IDA: Inferred from Direct Assay |
F |
From MGI |
|||
| GO:0004563 |
beta-N-acetylhexosaminidase activity |
MGI:MGI:54946 |
IDA: Inferred from Direct Assay |
F |
From MGI |
|||
| GO:0004563 |
beta-N-acetylhexosaminidase activity |
MGI:MGI:78473 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:2429701 |
F |
From MGI |
||
| GO:0004563 |
beta-N-acetylhexosaminidase activity |
MGI:MGI:83770 |
IGI: Inferred from Genetic Interaction |
MGI:MGI:96073 |
F |
From MGI |
||
| GO:0004563 |
beta-N-acetylhexosaminidase activity |
MGI:MGI:86774 |
IDA: Inferred from Direct Assay |
F |
From MGI |
|||
| GO:0005625 |
soluble fraction |
MGI:MGI:4417868 |
ISO: Inferred from Sequence Orthology |
NCBI:NP_001011946 |
C |
From MGI |
||
| GO:0005764 |
lysosome |
MGI:MGI:3033879 |
IDA: Inferred from Direct Assay |
C |
From MGI |
|||
| GO:0005764 |
lysosome |
MGI:MGI:4417868 |
ISO: Inferred from Sequence Orthology |
NCBI:NP_001011946 |
C |
From MGI |
||
| GO:0005975 |
carbohydrate metabolic process |
MGI:MGI:2152098 |
IEA: Inferred from Electronic Annotation |
P |
From MGI |
|||
| GO:0006044 |
N-acetylglucosamine metabolic process |
MGI:MGI:4417868 |
ISO: Inferred from Sequence Orthology |
NCBI:NP_001011946 |
P |
From MGI |
||
| GO:0006687 |
glycosphingolipid metabolic process |
MGI:MGI:78473 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:2429701 |
P |
From MGI |
||
| GO:0006689 |
ganglioside catabolic process |
MGI:MGI:1271008 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:2429701 |
P |
From MGI |
||
| GO:0006689 |
ganglioside catabolic process |
MGI:MGI:1331265 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0006689 |
ganglioside catabolic process |
MGI:MGI:2670850 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0006689 |
ganglioside catabolic process |
MGI:MGI:3041658 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0006689 |
ganglioside catabolic process |
MGI:MGI:3573807 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0006689 |
ganglioside catabolic process |
MGI:MGI:76816 |
IMP: Inferred from Mutant Phenotype |
P |
From MGI |
|||
| GO:0006689 |
ganglioside catabolic process |
MGI:MGI:78473 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:2429701 |
P |
From MGI |
||
| GO:0006689 |
ganglioside catabolic process |
MGI:MGI:894862 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0006874 |
cellular calcium ion homeostasis |
MGI:MGI:2670850 |
IGI: Inferred from Genetic Interaction |
MGI:MGI:88110 |
P |
From MGI |
||
| GO:0006874 |
cellular calcium ion homeostasis |
MGI:MGI:2670850 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0007040 |
lysosome organization |
MGI:MGI:1271008 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:2429701 |
P |
From MGI |
||
| GO:0007040 |
lysosome organization |
MGI:MGI:78473 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:2429701 |
P |
From MGI |
||
| GO:0007040 |
lysosome organization |
MGI:MGI:83770 |
IGI: Inferred from Genetic Interaction |
MGI:MGI:96073 |
P |
From MGI |
||
| GO:0007040 |
lysosome organization |
MGI:MGI:894634 |
IGI: Inferred from Genetic Interaction |
MGI:MGI:96073 |
P |
From MGI |
||
| GO:0007338 |
single fertilization |
MGI:MGI:2670850 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:2429701 |
P |
From MGI |
||
| GO:0007341 |
penetration of zona pellucida |
MGI:MGI:3582046 |
IMP: Inferred from Mutant Phenotype |
P |
From MGI |
|||
| GO:0007605 |
sensory perception of sound |
MGI:MGI:83770 |
IGI: Inferred from Genetic Interaction |
MGI:MGI:96073 |
P |
From MGI |
||
| GO:0007626 |
locomotory behavior |
MGI:MGI:76799 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0007626 |
locomotory behavior |
MGI:MGI:83770 |
IGI: Inferred from Genetic Interaction |
MGI:MGI:96073 |
P |
From MGI |
||
| GO:0008049 |
male courtship behavior |
MGI:MGI:2450169 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:2429701 |
P |
From MGI |
||
| GO:0008360 |
regulation of cell shape |
MGI:MGI:3044466 |
IMP: Inferred from Mutant Phenotype |
P |
From MGI |
|||
| GO:0008654 |
phospholipid biosynthetic process |
MGI:MGI:3047051 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0009313 |
oligosaccharide catabolic process |
MGI:MGI:1331265 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0009313 |
oligosaccharide catabolic process |
MGI:MGI:3573807 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0015929 |
hexosaminidase activity |
MGI:MGI:4417868 |
ISO: Inferred from Sequence Orthology |
NCBI:NP_001011946 |
F |
From MGI |
||
| GO:0016020 |
membrane |
MGI:MGI:3033879 |
IDA: Inferred from Direct Assay |
C |
From MGI |
|||
| GO:0016231 |
beta-N-acetylglucosaminidase activity |
MGI:MGI:4417868 |
ISO: Inferred from Sequence Orthology |
NCBI:NP_001011946 |
F |
From MGI |
||
| GO:0016787 |
hydrolase activity |
MGI:MGI:1354194 |
IEA: Inferred from Electronic Annotation |
UniProtKB-KW:KW-0378 |
F |
From MGI |
||
| GO:0016798 |
hydrolase activity, acting on glycosyl bonds |
MGI:MGI:1354194 |
IEA: Inferred from Electronic Annotation |
UniProtKB-KW:KW-0326 |
F |
From MGI |
||
| GO:0019915 |
lipid storage |
MGI:MGI:1331265 |
IGI: Inferred from Genetic Interaction |
MGI:MGI:1342057 |
P |
From MGI |
||
| GO:0019915 |
lipid storage |
MGI:MGI:1331265 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0019915 |
lipid storage |
MGI:MGI:76799 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0019915 |
lipid storage |
MGI:MGI:78473 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:2429701 |
P |
From MGI |
||
| GO:0019915 |
lipid storage |
MGI:MGI:894862 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0019953 |
sexual reproduction |
MGI:MGI:1271008 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:2429701 |
P |
From MGI |
||
| GO:0030203 |
glycosaminoglycan metabolic process |
MGI:MGI:83770 |
IGI: Inferred from Genetic Interaction |
MGI:MGI:96073 |
P |
From MGI |
||
| GO:0030246 |
carbohydrate binding |
MGI:MGI:4417868 |
ISO: Inferred from Sequence Orthology |
NCBI:NP_001011946 |
F |
From MGI |
||
| GO:0031323 |
regulation of cellular metabolic process |
MGI:MGI:3047051 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0042552 |
myelination |
MGI:MGI:894634 |
IGI: Inferred from Genetic Interaction |
MGI:MGI:96073 |
P |
From MGI |
||
| GO:0042803 |
protein homodimerization activity |
MGI:MGI:2154458 |
ISO: Inferred from Sequence Orthology |
F |
From MGI |
|||
| GO:0042803 |
protein homodimerization activity |
MGI:MGI:3582046 |
IDA: Inferred from Direct Assay |
F |
From MGI |
|||
| GO:0042803 |
protein homodimerization activity |
MGI:MGI:4417868 |
ISO: Inferred from Sequence Orthology |
NCBI:NP_001011946 |
F |
From MGI |
||
| GO:0043169 |
cation binding |
MGI:MGI:2152098 |
IEA: Inferred from Electronic Annotation |
F |
From MGI |
|||
| GO:0043615 |
astrocyte cell migration |
MGI:MGI:3044466 |
IMP: Inferred from Mutant Phenotype |
P |
From MGI |
|||
| GO:0044267 |
cellular protein metabolic process |
MGI:MGI:3041658 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
MGI:MGI:3044466 |
IMP: Inferred from Mutant Phenotype |
P |
From MGI |
|||
| GO:0046982 |
protein heterodimerization activity |
MGI:MGI:2154458 |
ISO: Inferred from Sequence Orthology |
F |
From MGI |
|||
| GO:0046982 |
protein heterodimerization activity |
MGI:MGI:4417868 |
ISO: Inferred from Sequence Orthology |
NCBI:NP_001011946 |
F |
From MGI |
||
| GO:0048477 |
oogenesis |
MGI:MGI:894862 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:2429701 |
P |
From MGI |
||
| GO:0050885 |
neuromuscular process controlling balance |
MGI:MGI:1203907 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0050885 |
neuromuscular process controlling balance |
MGI:MGI:1331265 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0050885 |
neuromuscular process controlling balance |
MGI:MGI:76799 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0050885 |
neuromuscular process controlling balance |
MGI:MGI:83770 |
IGI: Inferred from Genetic Interaction |
MGI:MGI:96073 |
P |
From MGI |
||
| GO:0050905 |
neuromuscular process |
MGI:MGI:1203907 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0050905 |
neuromuscular process |
MGI:MGI:1331265 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
||
| GO:0050905 |
neuromuscular process |
MGI:MGI:76799 |
IMP: Inferred from Mutant Phenotype |
MGI:MGI:1857438 |
P |
From MGI |
| |
| edit table |
Notes
References
See Help:References for how to manage references in GONUTS.
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Sango K et al. (1996) Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nat Genet 14: 348-52 PubMed GONUTS page
- ↑ 2.0 2.1 2.2 Suzuki K et al. (1997) Mice deficient in all forms of lysosomal beta-hexosaminidase show mucopolysaccharidosis-like pathology. J Neuropathol Exp Neurol 56: 693-703 PubMed GONUTS page
- ↑ 3.0 3.1 3.2 3.3 Miller DJ et al. (1993) Sperm require beta-N-acetylglucosaminidase to penetrate through the egg zona pellucida. Development 118: 1279-89 PubMed GONUTS page
- ↑ Yuziuk JA et al. (1998) Specificity of mouse GM2 activator protein and beta-N-acetylhexosaminidases A and B. Similarities and differences with their human counterparts in the catabolism of GM2. J Biol Chem 273: 66-72 PubMed GONUTS page
- ↑ 5.0 5.1 5.2 Lankar D et al. (2002) Dynamics of major histocompatibility complex class II compartments during B cell receptor-mediated cell activation. J Exp Med 195: 461-72 PubMed GONUTS page
- ↑ Gibb S et al. (1981) Reduced pigmentation (rp), a new coat colour gene with effects on kidney lysosomal glycosidases in the mouse. Genet Res 37: 95-103 PubMed GONUTS page
- ↑ 7.0 7.1 7.2 7.3 7.4 Phaneuf D et al. (1996) Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum Mol Genet 5: 1-14 PubMed GONUTS page
- ↑ Ohshima T et al. (1997) alpha-Galactosidase A deficient mice: a model of Fabry disease. Proc Natl Acad Sci U S A 94: 2540-4 PubMed GONUTS page
- ↑ 9.0 9.1 9.2 Trasler J et al. (1998) Characterization of the testis and epididymis in mouse models of human Tay Sachs and Sandhoff diseases and partial determination of accumulated gangliosides. Endocrinology 139: 3280-8 PubMed GONUTS page
- ↑ 10.0 10.1 10.2 10.3 10.4 10.5 Liu Y et al. (1999) A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest 103: 497-505 PubMed GONUTS page
- ↑ 11.0 11.1 11.2 11.3 Pelled D et al. (2003) Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin. J Biol Chem 278: 29496-501 PubMed GONUTS page
- ↑ 12.0 12.1 Suzuki K et al. (2003) Neuronal accumulation of alpha- and beta-synucleins in the brain of a GM2 gangliosidosis mouse model. Neuroreport 14: 551-4 PubMed GONUTS page
- ↑ 13.0 13.1 Tsuji D et al. (2005) Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates. J Neurochem 92: 1497-507 PubMed GONUTS page
- ↑ Veal EA & Jackson MJ (1995) Expression of c-fos and c-myc in satellite cell cultures from dystrophic mdx and control mouse muscle. Biochem Soc Trans 23: 456S PubMed GONUTS page
- ↑ 15.0 15.1 15.2 Liu Y et al. (1997) Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment. Proc Natl Acad Sci U S A 94: 8138-43 PubMed GONUTS page
- ↑ 16.0 16.1 16.2 16.3 Sango K et al. (1995) Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat Genet 11: 170-6 PubMed GONUTS page
- ↑ Juneja SC (2002) Development of infertility at young adult age in a mouse model of human Sandhoff disease. Reprod Fertil Dev 14: 407-12 PubMed GONUTS page
- ↑ 18.0 18.1 18.2 Wu YP & Proia RL (2004) Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice. Proc Natl Acad Sci U S A 101: 8425-30 PubMed GONUTS page
- ↑ 19.0 19.1 Buccoliero R et al. (2004) Phospholipid synthesis is decreased in neuronal tissue in a mouse model of Sandhoff disease. J Neurochem 90: 80-8 PubMed GONUTS page
- ↑ 20.0 20.1 Liao MJ et al. (1998) No requirement for V(D)J recombination in p53-deficient thymic lymphoma. Mol Cell Biol 18: 3495-501 PubMed GONUTS page